Salarius Pharmaceuticals(SLRX) - 2020 Q2 - Earnings Call Transcript

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) Q2 2020 Earnings Conference Call August 12, 2020 4:30 PM ET Company Participants David Arthur - CEO, President & Director Mark Rosenblum - EVP, Finance & CFO Nadeem Mirza - SVP, Clinical Development Daniela Santiesteban - Director, Research and Business Development Conference Call Participants Aydin Huseynov - The Benchmark Company Wangzhi Li - Ladenburg Thalmann & Co. Hunter Diamond - Diamond Equity Research Patrick Doolan - Old Peak Road Operator Ladies and gen ...